FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to chemical compounds of the general formula (I):
wherein n = 1, 2 or 3; R1 and R2 are taken independently among hydrogen atom and alkyl; R3 represents alkyl; R4-R7 are taken independently among hydrogen, halogen atom, hydroxy-group, alkyl, aryl, alkoxy-group, aryloxy-, alkylthio-, arylthio-group, alkylsulfoxyl, alkylsulfonyl, arylsulfoxyl, arylsulfonyl, amino-, monoalkylamino-, dialkylamino-, nitro-, cyano-group, carboxaldehyde, alkylcarbonyl, arylcarbonyl, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino-, aminocarbonyloxy-, monoalkylaminocarbonyloxy-, dialkylaminocarbonyloxy-, monoalkylaminocarbonylamino- and dialkylaminocarbonylamino-group; or R5 and R6 form in common carbocyclic or heterocyclic ring, its pharmaceutically acceptable salts and prodrugs. Invention relates to a method for treatment and pharmaceutical composition eliciting properties of 5-HT2 agonist also.
EFFECT: valuable medicinal properties of compounds.
30 cl, 2 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY | 1996 |
|
RU2167155C2 |
| TRICYCLIC NITROGEN-CONTAINING COMPOUNDS AND TETRAHYDROQUINOLINE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1991 |
|
RU2023712C1 |
| NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
| DERIVATIVES OF PYRIDAZINOQUINOLINE | 1994 |
|
RU2279432C2 |
| SUBSTITUTED 4-IMIDAZOLES, METHOD FOR PREPARING AND USING THEM | 2007 |
|
RU2456281C2 |
| DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
| SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2278863C2 |
| VAR2CSA-DRUG CONJUGATES | 2014 |
|
RU2714933C2 |
| PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR CANCER TREATMENT | 2013 |
|
RU2672916C2 |
| RACEMIC AND OPTIC ACTIVE DERIVATIVES OF TETRALIN AND 7-HYDROXYTETRALIN | 1992 |
|
RU2073673C1 |
